Formal Analysis of Fairness for Optimistic Multiparty Contract Signing Protocol

Optimistic multiparty contract signing (OMPCS) protocols are proposed for exchanging multiparty digital signatures in a contract. Compared with general two-party exchanging protocols, such protocols are more complicated, because the number of protocol messages and states increases considerably when signatories increase. Moreover, fairness property in such protocols requires protection from each signatory rather than from an external hostile agent. It thus presents a challenge for formal verification. In our analysis, we employ and combine the strength of extended modeling language CSP# and linear temporal logic (LTL) to verify the fairness of OMPCS protocols. Furthermore, for solving or mitigating the state space explosion problem, we set a state reduction algorithm which can decrease the redundant states properly and reduce the time and space complexity greatly. Finally, this paper illustrates the feasibility of our approach by analyzing the GM and CKS protocols, and several fairness flaws have been found in certain computation times

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Research on Image Splicing and Fusion Processing Algorithm in Large Visual Field

To obtain wide area and a large field of view image, splicing and fusion algorithm is presented. Single image is preprocessed by utilizing rough matching algorithm, which can narrow down the matching range to improve the speed and precision of image stitching and fusion, at the same time, Single image is preprocessed by filter processing algorithm, which will reduce interference noise, improve SNR and enhance the effective character information of image; the best matching position is found by using a combined splicing algorithm, which are ratio template matching algorithm and template matching algorithm, and the images are spliced at the best matching position; we take the neighborhood weighted average fusion algorithm to eliminate the distinct splicing trace. The captured images are processed by using correlation algorithm, a large field of view and high quality image is obtained. The experimental results verify the validity of the algorithm

EEG Feature Analysis Related to Situation Awareness Assessment and Discrimination

In order to discriminate situation awareness (SA) levels on the basis of SA-sensitive electroencephalography (EEG) features, the high-SA (HSA) group and low-SA (LSA) groups, which are representative of two SA levels, were classified according to the situation awareness global assessment technology (SAGAT) scores measured in the multi-attribute task battery (MATB) II tasks. Furthermore, three types of EEG features, namely, absolute power, relative power, and slow-wave/fast-wave (SW/FW), were explored using spectral analysis. In addition, repeated analysis of variance (ANOVA) was conducted in three brain regions (frontal, central, and parietal) × three brain lateralities (left, middle, and right) × two SA groups (LSA and HSA) to explore SA-sensitive EEG features. The statistical results indicate a significant difference between the two SA groups according to SAGAT scores; moreover, no significant difference was found for the absolute power of four waves (delta (δ), theta (θ), alpha (α), and beta (β)). In addition, the LSA group had a significantly lower β relative power than the HSA group in central and partial regions. Lastly, compared with the HSA group, the LSA group had higher θ/β and (θ + α)/(α + β) in all analyzed brain regions, higher α/β in the parietal region, and higher (θ + α)/β in all analyzed regions except for the left and right laterality in the frontal region. The above SA-sensitive EEG features were fed into principal component analysis (PCA) and the Bayes method to discriminate different SA groups, and the accuracies were 83.3% for the original validation and 70.8% for the cross-validation. The results provide a basis for real-time assessment and discrimination of SA by investigating EEG features, thus contributing to monitoring SA decrement that might lead to threats to flight safety

EEG Feature Analysis Related to Situation Awareness Assessment and Discrimination

In order to discriminate situation awareness (SA) levels on the basis of SA-sensitive electroencephalography (EEG) features, the high-SA (HSA) group and low-SA (LSA) groups, which are representative of two SA levels, were classified according to the situation awareness global assessment technology (SAGAT) scores measured in the multi-attribute task battery (MATB) II tasks. Furthermore, three types of EEG features, namely, absolute power, relative power, and slow-wave/fast-wave (SW/FW), were explored using spectral analysis. In addition, repeated analysis of variance (ANOVA) was conducted in three brain regions (frontal, central, and parietal) × three brain lateralities (left, middle, and right) × two SA groups (LSA and HSA) to explore SA-sensitive EEG features. The statistical results indicate a significant difference between the two SA groups according to SAGAT scores; moreover, no significant difference was found for the absolute power of four waves (delta (δ), theta (θ), alpha (α), and beta (β)). In addition, the LSA group had a significantly lower β relative power than the HSA group in central and partial regions. Lastly, compared with the HSA group, the LSA group had higher θ/β and (θ + α)/(α + β) in all analyzed brain regions, higher α/β in the parietal region, and higher (θ + α)/β in all analyzed regions except for the left and right laterality in the frontal region. The above SA-sensitive EEG features were fed into principal component analysis (PCA) and the Bayes method to discriminate different SA groups, and the accuracies were 83.3% for the original validation and 70.8% for the cross-validation. The results provide a basis for real-time assessment and discrimination of SA by investigating EEG features, thus contributing to monitoring SA decrement that might lead to threats to flight safety

Stage 1 hypertension defined by the 2017 ACC/AHA blood pressure guideline and cardiometabolic multimorbidity in Chinese adults

Abstract The association of blood pressure (BP) classification defined by the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline with cardiometabolic multimorbidity (CMM) remains unclear. The present study aimed to investigate this research gap in the Chinese adults. Cross‐sectional data were collected from a population‐based cohort conducted in Southern China. Participants were categorized as having normal BP, elevated BP, stage 1 hypertension, and stage 2 hypertension according to the 2017 ACC/AHA guideline. CMM was defined as having two or more of the following diseases: coronary heart disease, stroke, and diabetes. The relationship between the BP classifications and CMM was examined by multivariate logistic regression. A total of 95 649 participants (mean age: 54.3 ± 10.2 years, 60.7% were women) were enrolled in this study. Multivariable‐adjusted logistic regression models revealed that stage 1 hypertension (odds ratio [OR], 1.35; 95% confidence interval [CI], 1.03–1.78) and stage 2 hypertension (OR, 3.53; 95% CI, 2.82–4.47) were significantly associated with a higher prevalence of CMM compared with normal BP. The association between stage 1 hypertension and CMM were profound in women (OR, 1.76; 95% CI, 1.17–2.67) and in the middle‐aged group (OR, 1.53; 95% CI, 1.02–2.35) compared with men and older individuals, respectively. Our study showed that among Chinese adults, stage 1 hypertension defined by the 2017 ACC/AHA guideline was already associated with higher odds of CMM compared with normal BP, particularly in women and middle‐aged participants. Managing stage 1 hypertension may be an important measure to prevent CMM in Chinese adults

Outstanding fracture toughness combines gigapascal yield strength in an N-doped heterostructured medium-entropy alloy

The superior strength and toughness balance prevails in the face-centered-cubic-structured high/medium-entropy alloys (H/MEAs) of low strength, while a gain in yield strength is normally accompanied by a sacrifice in toughness, leading to the strength and toughness trade-off particularly when yield strength increases to the gigapascal levels. Here, we showed the superior fracture toughness by heterostructuring an N-doped CrCoNi MEA having different levels of yield strength higher than 1 GPa. The fracture toughness was 91 MPa.m(1/2) at yield strength of 1.3 GPa in the heterogeneous lamella structure and 168 MPa.m(1/2) at yield strength of 1.0 GPa in the heterogeneous grain structure. The fracture toughness was attributed to forest hardening plus an extra hetero-deformation induced hardening. The pile-ups of geometrically necessary dislocations were observed to be formed at the domain boundaries to accommodate strain gradient at the plastic zone of the crack tip. The chemical short-range orders were found for the enhanced strain hardening near the crack tip by the interaction with dislocations. Moreover, a new parameter was proposed to characterize the work hardening capacity at the crack tip by the integral of hardness increment in the plastic zone which shows a linear relation-ship with the J-integral value during the crack initiation